Reconstitution of maturating and regulatory lymphocyte subsets after cord blood and BMT in children

Bone Marrow Transplantation

Volumn 48, Issue 3, 2013, Pages 376-382

  Charrier, E ^a,b   Cordeiro, P ^a   Brito, R M ^a   Mezziani, S ^a   Herblot, S ^a,d   Le Deist, F ^a,c,d   Duval, M ^a,b,c,d  

^a UNIVERSITY OF MONTREAL   (Canada)

^b Département de Sciences Biomédicales   (Canada)

^c Département de Microbiologie et d'Immunologie   (Canada)

^d UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

BMT; cord blood transplantation; immune reconstitution; lymphocyte subpopulations; thymopoiesis

Indexed keywords

CD27 ANTIGEN; CD31 ANTIGEN; CD4 ANTIGEN; CD45RA ANTIGEN; CD45RO ANTIGEN; CD56 ANTIGEN; INTERLEUKIN 2 RECEPTOR ALPHA; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR 2DL1; NATURAL KILLER CELL RECEPTOR NKG2A; TRANSCRIPTION FACTOR FOXP3;

ADOLESCENT; ADULT; ARTICLE; BONE MARROW TRANSPLANTATION; CD3+ T LYMPHOCYTE; CD4 CD8 RATIO; CD4 LYMPHOCYTE COUNT; CELL EXPANSION; CELL MATURATION; CHILD; CONTROLLED STUDY; CORD BLOOD STEM CELL TRANSPLANTATION; HUMAN; LYMPHOCYTE SUBPOPULATION; MAJOR CLINICAL STUDY; MEMORY CELL; NATURAL KILLER T CELL; PHENOTYPE; PRESCHOOL CHILD; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; SCHOOL CHILD;

ADOLESCENT; BONE MARROW TRANSPLANTATION; CHILD; COHORT STUDIES; FEMALE; FETAL BLOOD; HUMANS; KILLER CELLS, NATURAL; LEUKEMIA; LYMPHOCYTE SUBSETS; LYMPHOCYTES; MALE; T-LYMPHOCYTES, REGULATORY;

EID: 84875214692     PISSN: 02683369     EISSN: 14765365     Source Type: Journal    
DOI: 10.1038/bmt.2012.176     Document Type: Article

References (48)

1. Eapen M, Rubinstein P, Zhang MJ, Stevens C, Kurtzberg J, Scaradavou A et al. Outcomes of transplantation of unrelated donor umbilical cord blood and bone marrow in children with acute leukaemia: a comparison study. Lancet 2007; 369: 1947-1954.
2. Thomson BG, Robertson KA, Gowan D, Heilman D, Broxmeyer HE, Emanuel D et al. Analysis of engraftment, graft-versus-host disease, and immune recovery following unrelated donor cord blood transplantation. Blood 2000; 96: 2703-2711.
3. Barker JN, Hough RE, van Burik JA, DeFor TE, MacMillan ML, O'Brien MR et al. Serious infections after unrelated donor transplantation in 136 children: impact of stem cell source. Biol Blood Marrow Transplant 2005; 11: 362-370.
4. van Burik JA, Burnstein GC. Infectious complications following unrelated cord blood transplantation. Vox Sang 2007; 92: 289-296.
5. Parody R, Martino R, Rovira M, Vazquez L, Vazquez MJ, de la Camara R et al. Severe infections after unrelated donor allogeneic hematopoietic stem cell transplantation in adults: comparison of cord blood transplantation with peripheral blood and bone marrow transplantation. Biol Blood Marrow Transplant 2006; 12: 734-748.
6. Renard C, Barlogis V, Mialou V, Galambrun C, Bernoux D, Goutagny MP et al. Lymphocyte subset reconstitution after unrelated cord blood or bone marrow transplantation in children. Br J Haematol 2010; 152: 322-330.
7. Talvensaari K, Clave E, Douay C, Rabian C, Garderet L, Busson M et al. A broad T-cell repertoire diversity and an efficient thymic function indicate a favorable long-term immune reconstitution after cord blood stem cell transplantation. Blood 2002; 99: 1458-1464.
8. Giraud P, Thuret I, Reviron D, Chambost H, Brunet C, Novakovitch G et al. Immune reconstitution and outcome after unrelated cord blood transplantation: a single paediatric institution experience. Bone Marrow Transplant 2000; 25: 53-57.
9. Jacobson CA, Turki AT, McDonough SM, Stevenson KE, Kim HT, Kao G et al. Immune reconstitution after double umbilical cord blood stem cell transplantation: comparison with unrelated peripheral blood stem cell transplantation. Biol Blood Marrow Transplant 2012; 18: 565-574.
10. Cohen G, Carter SL, Weinberg KI, Masinsin B, Guinan E, Kurtzberg J et al. Antigen-specific T-lymphocyte function after cord blood transplantation. Biol Blood Marrow Transplant 2006; 12: 1335-1342.
11. Beziat V, Nguyen S, Lapusan S, Hervier B, Dhedin N, Bories D et al. Fully functional NK cells after unrelated cord blood transplantation. Leukemia 2009; 23: 721-728.
12. Tanaka J, Sugita J, Asanuma S, Arita K, Shono Y, Kikutchi M et al. Increased number of CD16(+)CD56(dim) NK cells in peripheral blood mononuclear cells after allogeneic cord blood transplantation. Hum Immunol 2009; 70: 701-705.
13. Jacobson CA, Turki AT, McDonough SM, Stevenson KE, Kim HT, Kao G et al. Immune reconstitution after double umbilical cord blood stem cell transplantation: comparison with unrelated peripheral blood stem cell transplantation. Biol Blood Marrow Transplant 2012; 18: 565-574.
14. Dutt S, Tseng D, Ermann J, George TI, Liu YP, Davis CR et al. Naive and memory T cells induce different types of graft-versus-host disease. J Immunol 2007; 179: 6547-6554.
15. Anderson BE, McNiff J, Yan J, Doyle H, Mamula M, Shlomchik MJ et al. Memory CD4 + T cells do not induce graft-versus-host disease. J Clin Invest 2003; 112: 101-108.
16. Zheng H, Matte-Martone C, Li H, Anderson BE, Venketesan S, Sheng Tan H et al. Effector memory CD4 + T cells mediate graft-versus-leukemia without inducing graft-versus-host disease. Blood 2008; 111: 2476-2484.
17. Zhang Y, Joe G, Hexner E, Zhu J, Emerson SG. Host-reactive CD8 + memory stem cells in graft-versus-host disease. Nat Med 2005; 11: 1299-1305.
18. Zhang Y, Joe G, Hexner E, Zhu J, Emerson SG. Alloreactive memory T cells are responsible for the persistence of graft-versus-host disease. J Immunol 2005; 174: 3051-3058.
19. Kohler S, Thiel A. Life after the thymus: CD31+ and CD31-human naive CD4 + T-cell subsets. Blood 2009; 113: 769-774.
20. Kimmig S, Przybylski GK, Schmidt CA, Laurisch K, Mowes B, Radbruch A et al. Two subsets of naive T helper cells with distinct T cell receptor excision circle content in human adult peripheral blood. J Exp Med 2002; 195: 789-794.
21. Storek J, Ferrara S, Ku N, Giorgi JV, Champlin RE, Saxon A. B cell reconstitution after human bone marrow transplantation: recapitulation of ontogeny? Bone Marrow Transplant 1993; 12: 387-398.
22. D'Orsogna LJ, Wright MP, Krueger RG, McKinnon EJ, Buffery SI, Witt CS et al. Allogeneic hematopoietic stem cell transplantation recipients have defects of both switched and igm memory B cells. Biol Blood Marrow Transplant 2009; 15: 795-803.
23. Avanzini MA, Locatelli F, Dos Santos C, Maccario R, Lenta E, Oliveri M et al. B lymphocyte reconstitution after hematopoietic stem cell transplantation: functional immaturity and slow recovery of memory CD27+ B cells. Exp Hematol 2005; 33: 480-486.
24. Yu J, Mao HC, Wei M, Hughes T, Zhang J, Park IK et al. CD94 surface density identifies a functional intermediary between the CD56bright and CD56dim human NK-cell subsets. Blood 2010; 115: 274-281.
25. Bjorkstrom NK, Riese P, Heuts F, Andersson S, Fauriat C, Ivarsson MA et al. Expression patterns of NKG2A, KIR, and CD57 define a process of CD56dim NK-cell differentiation uncoupled from NK-cell education. Blood 2010; 116: 3853-3864.
26. Beziat V, Descours B, Parizot C, Debre P, Vieillard VNK. cell terminal differentiation: correlated stepwise decrease of NKG2A and acquisition of KIRs. PLoS One 2010; 5: e11966.
27. Bendelac A, Savage PB, Teyton L. The biology of NKT cells. Annu Rev Immunol 2007; 25: 297-336.
28. Morris ES, MacDonald KP, Rowe V, Banovic T, Kuns RD, Don AL et al. NKT cell-dependent leukemia eradication following stem cell mobilization with potent G-CSF analogs. J Clin Invest 2005; 115: 3093-3103.
29. Kuns RD, Morris ES, Macdonald KP, Markey KA, Morris HM, Raffelt NC et al. Invariant natural killer T cell-natural killer cell interactions dictate transplantation outcome after alpha-galactosylceramide administration. Blood 2009; 113: 5999-6010.
30. Tolar J, Hippen KL, Blazar BR. Immune regulatory cells in umbilical cord blood: T regulatory cells and mesenchymal stromal cells. Br J Haematol 2009; 147: 200-206.
31. Kim YJ, Broxmeyer HE. Immune regulatory cells in umbilical cord blood and their potential roles in transplantation tolerance. Crit Rev Oncol Hematol 2011; 79: 112-126.
32. Dalle JH, Duval M, Moghrabi A, Wagner E, Vachon MF, Barrette S et al. Results of an unrelated transplant search strategy using partially HLA-mismatched cord blood as an immediate alternative to HLA-matched bone marrow. Bone Marrow Transplant 2004; 33: 605-611.
33. Ruggeri A, Peffault de Latour R, Carmagnat M, Clave E, Douay C, Larghero J et al. Outcomes, infections, and immune reconstitution after double cord blood transplantation in patients with high-risk hematological diseases. Transpl Infect Dis 2011; 13: 456-465.
34. Komanduri St KV, John LS, de Lima M, McMannis J, Rosinski S, McNiece I et al. Delayed immune reconstitution after cord blood transplantation is characterized by impaired thymopoiesis and late memory T-cell skewing. Blood 2007; 110: 4543-4551.
35. Brown JA, Stevenson K, Kim HT, Cutler C, Ballen K, McDonough S et al. Clearance of CMV viremia and survival after double umbilical cord blood transplantation in adults depends on reconstitution of thymopoiesis. Blood 2010; 115: 4111-4119.
36. Merindol N, Salem FI, Brito RM, Grenier AJ, Charrier E, Cordeiro P et al. Reconstitution of protective immune responses against CMV and VZV does not require disease development in paediatric recipients of umbilical cord blood transplantation. J Immunol 2012 (in press).
37. Arakawa-Hoyt J, Dao MA, Thiemann F, Hao QL, Ertl DC, Weinberg KI et al. The number and generative capacity of human B lymphocyte progenitors, measured in vitro and in vivo, is higher in umbilical cord blood than in adult or pediatric bone marrow. Bone Marrow Transplant 1999; 24: 1167-1176.
38. Moretta A, Maccario R, Fagioli F, Giraldi E, Busca A, Montagna D et al. Analysis of immune reconstitution in children undergoing cord blood transplantation. Exp Hematol 2001; 29: 371-379.
39. Vandenbosch K, Ovetchkine P. Champagne MA, Haddad E, Alexandrov L, Duval M. Varicella-zoster virus disease is more frequent after cord blood than after bone marrow transplantation. Biol Blood Marrow Transplant 2008; 14: 867-871.
40. Freud AG, Caligiuri MA. Human natural killer cell development. Immunol Rev 2006; 214: 56-72.
41. Nguyen S, Dhedin N, Vernant JP, Kuentz M, Al Jijakli A, Rouas-Freiss N et al. NK-cell reconstitution after haploidentical hematopoietic stem-cell transplantations: immaturity of NK cells and inhibitory effect of NKG2A override GvL effect. Blood 2005; 105: 4135-4142.
42. Giebel S, Dziaczkowska J, Czerw T, Wojnar J, Krawczyk-Kulis M, Nowak I et al. Sequential recovery of NK cell receptor repertoire after allogeneic hematopoietic SCT. Bone Marrow Transplant 2010; 45: 1022-1030.
43. Haas P, Loiseau P, Tamouza R, Cayuela JM, Moins-Teisserenc H, Busson M et al. NK-cell education is shaped by donor HLA genotype after unrelated allogeneic hematopoietic stem cell transplantation. Blood 2010; 117: 1021-1029.
44. Cooley S, Xiao F, Pitt M, Gleason M, McCullar V, Bergemann TL et al. A sub-population of human peripheral blood NK cells that lacks inhibitory receptors for self-MHC is developmentally immature. Blood 2007; 110: 578-586.
45. Trenado A, Charlotte F, Fisson S, Yagello M, Klatzmann D, Salomon BL et al. Recipient-type specific CD4 + CD25 + regulatory T cells favor immune recon-stitution and control graft-versus-host disease while maintaining graft-versus-leukemia. J Clin Invest 2003; 112: 1688-1696.
46. Ukena SN, Velaga S, Geffers R, Grosse J, Baron U, Buchholz S et al. Human regulatory T cells in allogeneic stem cell transplantation. Blood 2011; 118: e82-e92.
47. de Lalla C, Rinaldi A, Montagna D, Azzimonti L, Bernardo ME, Sangalli LM et al. Invariant NKT cell reconstitution in pediatric leukemia patients given HLA-hap-loidentical stem cell transplantation defines distinct CD4 + and CD4-subset dynamics and correlates with remission state. J Immunol 2011; 186: 4490-4499.
48. Godfrey WR, Spoden DJ, Ge YG, Baker SR, Liu B, Levine BL et al. Cord blood CD4(+)CD25(+)-derived T regulatory cell lines express FoxP3 protein and manifest potent suppressor function. Blood 2005; 105: 750-758.